fda approved glp-1 gip medications 2025 The Novo Nordisk's once-daily oral Wegovy tablet on December 30, 2025, marking the first oral medication for obesity in the United States and representing a major shift in weight-loss Compounded GLP-1/GIP Injections Online |

Sarcopenia (muscle loss) due to rapid weight loss if measures to preserve muscle are not taken, including regular strength training, staying active, and eating a protein-rich diet

doi: 10.1016/j.appet.2019.104422

SN Comprehens Clin Med 3(4):10311041 Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1

However, while direct interference with the mechanism of action might be uncommon, the bodys response to both medications taken concurrently requires careful consideration

Other New Stuff: The Genetics of G-Agonists In a seminal study of the genomics of glucose regulation in nearly 500,000 people, specific coding variants of the GLP-1 receptor (GLP1R) were associated with potential GLP-1 drug response

Consuming adequate dietary protein is crucial for anyone engaging in strength training, and it becomes even more critical during weight loss, especially when using GLP-1 medications